Rocket Stocks for the Week
Not a Stockpickr member? Join the community today -- for free.
By Jonas Elmerraji
The markets continued their downward trend last week, spurred on by concerns over earnings and the state of the economy. The S&P 500 closed 1.93% lower on Friday. As we approach the coming week, all eyes are on where the market's headed next.
Futures were mixed leading into Monday's trading, giving rise to hopes that the market could turn things around and continue the rally that tapered off late last month. But while stocks fizzle, it's a great time to take a look at rocket stocks -- beaten-down stocks with short-term catalysts for growth and long-term investment potential.
Before we get to this week's list, here's a look at how last week's rocket stocks have fared. First on our list was Equifax (EFX), one of three companies consumers turn to when they want a credit report. We liked Equifax's deep economic moats and rebound potential as the market for consumer credit starts to loosen back up. On Thursday, the company announced that it would be releasing its second-quarter 2009 earnings on July 22. Analysts expect the company to deliver 57 cents per share. Equifax ended the week mostly flat, with a drop of 0.24%. Insurer American Financial Group (AFG) had a markedly better week, with a gain of 2.43%. Like Equifax, the company announced its second-quarter earnings release this week, scheduled for July 28. But a bigger price driver was AFG's selection to the 2008 list of Interactive Health Solutions' "Healthiest Companies in America" last Thursday. Stericycle (SRCL) is a medical waste company that we liked for the bottom-line boost that America's aging baby boomer population is sure to provide over the next several years, not to mention its recession resistance. But while the company held up well through 2008, last week proved more challenging as the stock slid 2.47% under pressure from technical traders.Select the service that is right for you!
COMPARE ALL SERVICESAction Alerts PLUS
TRY IT FREEJim Cramer and Stephanie Link actively manage a real portfolio and reveal their money management tactics while giving advanced notice before every trade.
Product Features:
- $2.5+ million portfolio
- Large-cap and dividend focus
- Intraday trade alerts from Cramer
- Weekly roundups
TheStreet Quant Ratings
TRY IT FREENew! $49.95/yr
Access the tool that DOMINATES the Russell 2000 and the S&P 500.
Product Features:
- Buy, hold, or sell recommendations for over 4,300 stocks
- Unlimited research reports on your favorite stocks
- A custom stock screener
- Upgrade/downgrade alerts
Stocks Under $10
TRY IT FREEDavid Peltier, uncovers low dollar stocks with extraordinary upside potential that are flying under Wall Street's radar.
Product Features:
- Model portfolio
- Stocks trading below $10
- Intraday trade alerts
- Weekly roundups
Dividend Stock Advisor
TRY IT FREEJim Cramer's protege, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.
Product Features:
- Diversified model portfolio of dividend stocks
- Alerts when market news affect the portfolio
- Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
Real Money Pro
TRY IT FREEAll of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.
Product Features:
- Real Money + Doug Kass + 15 more Wall Street Pros
- Intraday commentary & news
- Ultra-actionable trading ideas
Options Profits
TRY IT FREEOur options trading pros provide daily market commentary and over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.
Product Features:
- 100+ monthly options trading ideas
- Actionable options commentary & news
- Real-time trading community
- Options TV